Retrometabolic Approach for Designing Personalized Anti- Cancer Drug Molecules for Controlling Breast Cancer Resulted by BRCA1 Mutations

Publisher: Bentham Science Publishers

E-ISSN: 1875-6913|14|1|56-64

ISSN: 1875-6921

Source: Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol.14, Iss.1, 2017-01, pp. : 56-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content